NO20025399L - Fosfat transport inhibitorer - Google Patents

Fosfat transport inhibitorer

Info

Publication number
NO20025399L
NO20025399L NO20025399A NO20025399A NO20025399L NO 20025399 L NO20025399 L NO 20025399L NO 20025399 A NO20025399 A NO 20025399A NO 20025399 A NO20025399 A NO 20025399A NO 20025399 L NO20025399 L NO 20025399L
Authority
NO
Norway
Prior art keywords
transport inhibitors
phosphate transport
phosphate
inhibitors
transport
Prior art date
Application number
NO20025399A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025399D0 (no
Inventor
Joseph Weinstock
Gerald Girard
Dimitri Gaitanopoulos
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20025399D0 publication Critical patent/NO20025399D0/no
Publication of NO20025399L publication Critical patent/NO20025399L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20025399A 2000-05-12 2002-11-11 Fosfat transport inhibitorer NO20025399L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20399500P 2000-05-12 2000-05-12
PCT/US2001/015324 WO2001087294A1 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Publications (2)

Publication Number Publication Date
NO20025399D0 NO20025399D0 (no) 2002-11-11
NO20025399L true NO20025399L (no) 2002-11-11

Family

ID=22756167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025399A NO20025399L (no) 2000-05-12 2002-11-11 Fosfat transport inhibitorer

Country Status (14)

Country Link
JP (1) JP2003533477A (pl)
KR (1) KR20020093983A (pl)
CN (1) CN1429108A (pl)
AU (1) AU2001261471A1 (pl)
BR (1) BR0110034A (pl)
CA (1) CA2408667A1 (pl)
CZ (1) CZ20023701A3 (pl)
HU (1) HUP0302234A2 (pl)
IL (1) IL152587A0 (pl)
MX (1) MXPA02011160A (pl)
NO (1) NO20025399L (pl)
PL (1) PL359931A1 (pl)
WO (1) WO2001087294A1 (pl)
ZA (1) ZA200209106B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378179A (en) * 2001-08-03 2003-02-05 Pantherix Ltd Aromatic sulfonamides and their use in treating bacterial diseases
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
MX381407B (es) 2008-12-31 2025-03-12 Ardelyx Inc Compuestos y métodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrógeno (nhe) en el tratamiento de trastornos asociados con retención de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal.
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX366293B (es) 2012-08-21 2019-07-04 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103183623A (zh) * 2013-03-12 2013-07-03 中国医学科学院医药生物技术研究所 一组苯磺酰胺基苯甲酰胺类衍生物及制备和应用
HRP20191000T1 (hr) 2013-04-12 2019-09-20 Ardelyx, Inc. Spojevi za vezanje nhe3 i metode inhibiranja transporta fosfata
US9765050B2 (en) 2014-12-30 2017-09-19 Novira Therapeutics, Inc. Pyridyl reverse sulfonamides for HBV treatment
CN105395532B (zh) * 2015-11-25 2017-11-14 中国医学科学院医药生物技术研究所 2‑苯磺酰胺基苯甲酰胺类化合物在肝损伤保护和肝纤维化防治中的应用
EP3508475A4 (en) 2016-08-30 2020-04-15 Nippon Soda Co., Ltd. SULFONYLAMINO BENZAMIDE COMPOUND AND PEST CONTROL AGENT
MX2019008171A (es) 2017-01-09 2020-02-05 Ardelyx Inc Inhibidores del antiporte mediado por nhe.
MX395405B (es) 2017-01-09 2025-03-25 Ardelyx Inc Compuestos útiles para tratar trastornos del tracto gastrointestinal.
EP4140991B1 (en) * 2018-06-01 2024-05-15 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078145A1 (en) * 1999-06-24 2000-12-28 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists
AR030911A1 (es) * 1999-07-20 2003-09-03 Smithkline Beecham Corp Uso de n-aril-2-sulfonamidobenzamidas para la manufactura de un medicamento para el tratamiento de la insuficiencia renal cronica y composiciones farmaceuticas

Also Published As

Publication number Publication date
NO20025399D0 (no) 2002-11-11
JP2003533477A (ja) 2003-11-11
WO2001087294A1 (en) 2001-11-22
CN1429108A (zh) 2003-07-09
ZA200209106B (en) 2003-10-23
MXPA02011160A (es) 2003-03-10
CA2408667A1 (en) 2001-11-22
KR20020093983A (ko) 2002-12-16
AU2001261471A1 (en) 2001-11-26
IL152587A0 (en) 2003-05-29
PL359931A1 (pl) 2004-09-06
HUP0302234A2 (hu) 2003-11-28
BR0110034A (pt) 2003-05-27
CZ20023701A3 (cs) 2003-11-12

Similar Documents

Publication Publication Date Title
DE60002193D1 (de) Metalloprotease inhibitoren
ATE433451T1 (de) Xanthin-phosphodiesteras-v-inhibitoren
DE60017180D1 (de) Fab i inhibitoren
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
CY2012007I1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
ATE318603T1 (de) Pyrrolotriazin kinasehemmer
AU2002213048A1 (en) Phosphate transport inhibitors
PT1194404E (pt) Inibidores de aspartil-protease
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20014243D0 (no) Dihetero-substituerte metalloprotease inhibitorer
AU2001259354A1 (en) Phosphate transport inhibitors
NO20025399L (no) Fosfat transport inhibitorer
NO20014875L (no) Promedikamenter for trombin inhibitorer
DE50108962D1 (de) Transportanlage
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
NO20025786D0 (no) Protaseinhibitorer
PT1339695E (pt) Inibidores da farnesiltransferase
NO20024481D0 (no) Difluorbutyrsyre metalloproteaseinhibitorer
NO20025005L (no) Proteaseinhibitorer
IS6701A (is) Cdc25 fosfatasahemlar
DK1130214T3 (da) Korrosionsinhibitorer
AR028075A1 (es) Inhibidores de la peptido-desformilasa
DE60132468D1 (de) Alen-lanosterol zyklase inhibitoren
NO20032328D0 (no) Proteaseinhibitorer
ATA11912000A (de) Transportanlage

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application